A research team from the Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences has revealed ...

Researchers from Astrazeneca plc presented the discovery and preclinical characterization of AZD-9793, a novel CD8-guided T-cell engager (TCE) being developed for the treatment of hepatocellular ...

Biosciences announced the presentation of preclinical data investigating the potential of co-administration of ...

In a recent study published at *Cell Reports Medicine*the team identified three key success markers: the CD4:CD8 ratio, exhaustion signals and the expansion of gamma-delta cytotoxic T-cells. Taken ...

CD8 + T cells, and NK (natural killer) cells. Measurements showed that VNPs had lower zonulin levels, a marker indicating gut ...

In a recent study published at Cell Reports Medicine the team identified three key success markers: the CD4:CD8 ratio, exhaustion signals and the expansion of gamma-delta cytotoxic T-cells.